4 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-17-032202
Form type: Form 4
Filer: Revance Therapeutics, Inc.
CIK: CIK 1479290
Filed: May 12, 2017
Reporting period: May 11, 2017
Description: Insider transaction

Documents

0001209191-17-032202-index.htm

Complete submission

0001209191-17-032202.txt

directory listing

Filed by

Revance Therapeutics, Inc.